141 related articles for article (PubMed ID: 29107338)
1. Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea.
Woo YR; Kim JS; Lim JH; Hwang S; Kim M; Bae JM; Park YM; Min CK; Kim DW; Park HJ
J Am Acad Dermatol; 2018 Mar; 78(3):471-478.e4. PubMed ID: 29107338
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases.
Requena L; Kutzner H; Palmedo G; Calonje E; Requena C; Pérez G; Pastor MA; Sangueza OP
Arch Dermatol; 2003 Apr; 139(4):475-86. PubMed ID: 12707095
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case report.
Peterlin P; Ponge T; Blin N; Moreau P; Hamidou M; Agard C
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):373-4. PubMed ID: 21729687
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous involvement of multiple myeloma and extramedullary plasmacytoma.
Patterson JW; Parsons JM; White RM; Fitzpatrick JE; Kohout-Dutz E
J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):879-90. PubMed ID: 2461399
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous plasmacytosis: a clinicopathologic study of 12 cases in Taiwan revealing heterogeneous underlying causes.
Lu PH; Shih LY; Yang CH; Kuo TT
Int J Dermatol; 2015 Oct; 54(10):1132-7. PubMed ID: 26016536
[TBL] [Abstract][Full Text] [Related]
6. [Skin location of multiple myeloma mimicking a vascular tumor].
Jegou J; Derancourt C; Coindre JM; Leleu T; Perceau G; Bernard P
Ann Dermatol Venereol; 2001; 128(6-7):753-5. PubMed ID: 11460040
[TBL] [Abstract][Full Text] [Related]
7. Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas.
Kato N; Kimura K; Yasukawa K; Aikawa K
J Dermatol; 1999 Sep; 26(9):587-94. PubMed ID: 10535253
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation.
Malysz J; Talamo G; Zhu J; Clarke LE; Bayerl MG; Ali L; Helm KF; Chung CG
J Am Acad Dermatol; 2016 May; 74(5):878-84. PubMed ID: 26874821
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
Andrei M; Wang JC
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
[TBL] [Abstract][Full Text] [Related]
10. [Specific cutaneous involvement in patients with multiple myeloma. A clinicopathological, immunohistochemical and cytogenetic study of 40 cases].
Requena L
Actas Dermosifiliogr; 2005 Sep; 96(7):424-40. PubMed ID: 16476270
[TBL] [Abstract][Full Text] [Related]
11. Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas.
Bayer-Garner IB; Prieto VG; Smoller BR
Arch Pathol Lab Med; 2004 Jun; 128(6):645-8. PubMed ID: 15163236
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Nodules in Multiple Myeloma. Cutaneous plasmacytoma associated with multiple myeloma.
Gómez-Armayones S; Climent F; Servitje O
Actas Dermosifiliogr; 2015 Sep; 106(7):581-2. PubMed ID: 25935193
[No Abstract] [Full Text] [Related]
13. Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma.
Serefhanoglu S; Haznedaroglu IC; Goker H; Buyukasik Y; Ozcebe OI
Onkologie; 2009 Nov; 32(11):662-4. PubMed ID: 19887870
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological analysis in diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD38-positive plasma cells.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Nishiwaki U; Masuda Y; Hiraoka N; Takayama A; Nishimura Y; Tsuji M; Hanafusa T
Hematology; 2012 Nov; 17(6):317-20. PubMed ID: 23168070
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.
Jurczyszyn A; Olszewska-Szopa M; Hungria V; Crusoe E; Pika T; Delforge M; Leleu X; Rasche L; Nooka AK; Druzd-Sitek A; Walewski J; Davila J; Caers J; Maisnar V; Gertz M; Gentile M; Fantl D; Mele G; Vesole DH; Yee AJ; Shustik C; Lentzsch S; Zweegman S; Gozzetti A; Skotnicki AB; Castillo JJ
Leuk Lymphoma; 2016 Sep; 57(9):2071-6. PubMed ID: 26726867
[TBL] [Abstract][Full Text] [Related]
16. [A case of multiple myeloma with alternating paraprotein; non-secretory myeloma (IgG-kappa) converted to nonproducing myeloma, and finally to secretory myeloma (BJ-lambda) (author's transl)].
Fujii H; Kanoh T
Nihon Naika Gakkai Zasshi; 1981 Nov; 70(11):1553-61. PubMed ID: 6801164
[No Abstract] [Full Text] [Related]
17. A comparative analysis of cutaneous marginal zone lymphoma and cutaneous chronic lymphocytic leukemia.
Levin C; Mirzamani N; Zwerner J; Kim Y; Schwartz EJ; Sundram U
Am J Dermatopathol; 2012 Feb; 34(1):18-23. PubMed ID: 22257836
[TBL] [Abstract][Full Text] [Related]
18. [Secondary cutaneous plasmacytoma revealing multiple myeloma: about a case].
Ngolet LO; N'soundhat NL; Ndounga E; Kocko I; Kidédé DC; Ntsiba H
Pan Afr Med J; 2016; 24():44. PubMed ID: 27642385
[TBL] [Abstract][Full Text] [Related]
19. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
20. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
